Clinical Trials Browser

Carcinoma, Hepatocellular × elbasvir-grazoprevir drug combination × 1 year × Clear all

NCT02940496 2025-07-15

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Phase 2 Completed

15 enrolled 8 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular